#gsk — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #gsk, aggregated by home.social.
-
Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?
GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #Jemperli #NYSE
https://www.europesays.com/britain/117964/ -
https://www.europesays.com/britain/117964/ Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity? #GSK #GSKPlc #Jemperli #NYSE
-
HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma
Shanghai: GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED (China) $110 million…
#EuropeSays #Britain #Europe #EU #GSK #experimentalsolidtumourdrug #GlaxoSmithKline #HMPL-A830 #HUTCHMEDlicensingdeal #solidtumours
https://www.europesays.com/britain/117654/ -
https://www.europesays.com/britain/117654/ HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma #ExperimentalSolidTumourDrug #GlaxoSmithKline #GSK #HMPLA830 #HUTCHMEDLicensingDeal #SolidTumours
-
GSK advances mRNA flu shot after Phase II success
Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III…
#EuropeSays #Britain #Europe #EU #GSK #advances #after #Category:All #Category:CompanyNews #Category:MarketPulse #Category:MarketReport #Category:NewsandAnnouncements #Category:Sectorial:HealthTechnology #mRNA #Phase #shot #success
https://www.europesays.com/britain/117636/ -
Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK?
Moderna MRNA recently secured FDA approval for mFlusiva, the first mRNA-based seasonal flu vaccine. The decision is a…
#EuropeSays #Britain #Europe #EU #GSK #futures #indexmarketquote #indexmarketquotes #indexmarketsymbol #indexmarketsymbols #indices #ModernaInc #mRNA #TheGlobeandMail
https://www.europesays.com/britain/116951/ -
https://www.europesays.com/britain/116951/ Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK? #futures #GSK #IndexMarketQuote #IndexMarketQuotes #IndexMarketSymbol #IndexMarketSymbols #indices #ModernaInc #mRNA #TheGlobeAndMail
-
https://www.europesays.com/britain/116875/ Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK? #FDA #GSK #GSKPlcGSK #Inc #mFlusiva #Moderna #ModernaMRNA #mRNA #ZacksInvestmentResearch #ZacksInvestmentResearchModerna
-
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
GSK continues to look eastward for novel assets, this time partnering with Hong Kong-based HUTCHMED to develop an…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/116755/ -
https://www.europesays.com/britain/116414/ GSK Says Immune Response from mRNA Flu Shot Surpasses Licensed Competitors #Benzinga #BenzingaPro #GSK #GSKPlc #TheUSFoodAndDrugAdministration
-
GSK to Advance mRNA Influenza Vaccine Into Phase III Development – September 2, 2026
Key Takeaways GSK will begin a Phase III efficacy study of its mRNA flu vaccine later in September…
#EuropeSays #Britain #Europe #EU #GSK #Financial #financialplanning #investing #INVESTMENT #investmentadvice #onlineinvestment #onlinestocktrading #onlinetrading #quote #quotes #stock #Stockmarket #stockquotes #stocks
https://www.europesays.com/britain/116403/ -
https://www.europesays.com/britain/116403/ GSK to Advance mRNA Influenza Vaccine Into Phase III Development – September 2, 2026 #Financial #FinancialPlanning #GSK #investing #INVESTMENT #InvestmentAdvice #OnlineInvestment #OnlineStockTrading #OnlineTrading #quote #quotes #stock #StockMarket #StockQuotes #stocks
-
Pharmalittle: Shingles shot cuts heart risk, Mass. biotech jobs drop
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and…
#EuropeSays #Britain #Europe #EU #GSK #pharmalittle #STAT+
https://www.europesays.com/britain/111688/ -
https://www.europesays.com/britain/111688/ Pharmalittle: Shingles shot cuts heart risk, Mass. biotech jobs drop #GSK #pharmalittle #STAT+
-
Pharmalittle: FDA critical of Duchenne drug, GSK seeks savings
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our…
#EuropeSays #Britain #Europe #EU #GSK #pharmalittle #STAT+
https://www.europesays.com/britain/92491/ -
https://www.europesays.com/britain/92491/ Pharmalittle: FDA critical of Duchenne drug, GSK seeks savings #GSK #pharmalittle #STAT+
-
Pharmalittle: Drug shortages rise, GSK cough medicine trials fail
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
#EuropeSays #Britain #Europe #EU #GSK #pharmalittle #STAT+
https://www.europesays.com/britain/84958/ -
https://www.europesays.com/britain/84958/ Pharmalittle: Drug shortages rise, GSK cough medicine trials fail #GSK #pharmalittle #STAT+